APA (7th ed.) Citation

Wang, J., Xu, X., Wang, Y., & Zhu, Y. (2025). Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma. Cellular Oncology (2211-3428), 48(3), 775. https://doi.org/10.1007/s13402-025-01048-7

Chicago Style (17th ed.) Citation

Wang, Jiajun, Xianglai Xu, Ying Wang, and Yanjun Zhu. "Thymidine Kinase 1 Indicates Resistance to Immune Checkpoint Plus Tyrosine Kinase Inhibition in Renal Cell Carcinoma." Cellular Oncology (2211-3428) 48, no. 3 (2025): 775. https://doi.org/10.1007/s13402-025-01048-7.

MLA (9th ed.) Citation

Wang, Jiajun, et al. "Thymidine Kinase 1 Indicates Resistance to Immune Checkpoint Plus Tyrosine Kinase Inhibition in Renal Cell Carcinoma." Cellular Oncology (2211-3428), vol. 48, no. 3, 2025, p. 775, https://doi.org/10.1007/s13402-025-01048-7.